| 1 | Mastocytoma | 36.5% |
| 2 | Pyoderma Gangrenosum | 34.5% |
| 3 | Xeroderma Pigmentosum | 31.5% |
| 4 | Hyperpigmentation | 30.1% |
| 5 | Lupus Erythematosus, Cutaneous | 29.6% |
| 6 | Panniculitis | 29.6% |
| 7 | Systemic Scleroderma | 29.6% |
| 8 | Morphea | 29.6% |
| 9 | Acne Vulgaris | 27.5% |
| 10 | Contact Dermatitis | 27.5% |
| 11 | Eczema | 27.5% |
| 12 | Erythema Multiforme | 27.5% |
| 13 | Intertrigo | 27.5% |
| 14 | Neurodermatitis | 27.5% |
| 15 | Rhinophyma | 27.5% |
| 16 | Perioral Dermatitis | 27.5% |
| 17 | Acne | 27.5% |
| 18 | Breast Diseases | 27.3% |
| 19 | Dermatitis | 27.3% |
| 20 | Exanthema | 27.3% |
| 21 | Facial Dermatoses | 27.3% |
| 22 | Hair Diseases | 27.3% |
| 23 | Hand Dermatoses | 27.3% |
| 24 | keratoacanthoma | 27.3% |
| 25 | Keratosis | 27.3% |
| 26 | Nail Diseases | 27.3% |
| 27 | Photosensitivity Disorders | 27.3% |
| 28 | Prurigo | 27.3% |
| 29 | Pyoderma | 27.3% |
| 30 | Rosacea | 27.3% |
| 31 | Sebaceous Gland Diseases | 27.3% |
| 32 | Skin Diseases, Vesiculobullous | 27.3% |
| 33 | Skin Ulcer | 27.3% |
| 34 | Sweat Gland Diseases | 27.3% |
| 35 | Skin Diseases, Papulosquamous | 27.3% |
| 36 | Skin Diseases, Vascular | 27.3% |
| 37 | Acneiform Eruptions | 27.3% |
| 38 | Ocular Rosacea | 27.3% |
| 39 | Subcorneal pustular dermatosis | 27.3% |
| 40 | Erythematotelangiectatic Rosacea | 27.3% |
| 41 | Papulopustular Rosacea | 27.3% |
| 42 | Chronic Actinic Dermatitis | 27.3% |
| 43 | Dermatitis, Atopic | 26% |
| 44 | Epidermolysis Bullosa | 26% |
| 45 | Skin Neoplasms | 25% |
| 46 | Dermatitis, Phototoxic | 24.2% |
| 47 | Pityriasis Lichenoides et Varioliformis Acuta | 24.2% |
| 48 | Pityriasis Lichenoides | 24.2% |
| 49 | Phototoxicity | 24.2% |
| 50 | Argyria | 24.2% |
| 51 | Sebaceous Gland Neoplasms | 24.2% |
| 52 | Foot Ulcer | 23.4% |
| 53 | Dermatitis Herpetiformis | 23.2% |
| 54 | Acrodermatitis | 23% |
| 55 | Porokeratosis | 23% |
| 56 | Gianotti-Crosti Syndrome | 23% |
| 57 | Keratoderma, Palmoplantar | 23% |
| 58 | Foot Diseases | 22.8% |
| 59 | Panniculitis, Lupus Erythematosus | 22.4% |
| 60 | Skin Abnormalities | 22.2% |
| 61 | Skin Diseases, Infectious | 22.2% |
| 62 | Necrobiosis Lipoidica Diabeticorum | 22% |
| 63 | Lipomatosis | 21.9% |
| 64 | Pruritus | 21.9% |
| 65 | Erythema | 21.9% |
| 66 | Necrolytic Migratory Erythema | 21.9% |
| 67 | Cutaneous Fistula | 21.9% |
| 68 | Nephrogenic Fibrosing Dermopathy | 21.9% |
| 69 | Nephrogenic Systemic Fibrosis | 21.9% |
| 70 | Melanosis | 21.8% |
| 71 | Chloasma | 21.8% |
| 72 | Vitiligo | 21.8% |
| 73 | Dermatomyositis | 20.8% |
| 74 | Dermatitis, Photoallergic | 20.8% |
| 75 | Xeroderma | 19.9% |
| 76 | Erythema Induratum | 19.8% |
| 77 | Dermatitis, Irritant | 19.4% |
| 78 | Acne Conglobata | 19.4% |
| 79 | Lupus Erythematosus, Discoid | 18.3% |
| 80 | Scleroderma, Limited | 18.3% |
| 81 | Chondrosarcoma | 17.8% |
| 82 | synovial sarcoma | 17.8% |
| 83 | Clear Cell Sarcoma of Soft Tissue | 17.8% |
| 84 | Acanthosis Nigricans | 17.7% |
| 85 | Lentigo | 17.7% |
| 86 | Cutis Laxa | 17.7% |
| 87 | Pseudoxanthoma Elasticum | 17.6% |
| 88 | Ectodermal Dysplasia | 17.3% |
| 89 | Aplasia Cutis Congenita | 17.3% |
| 90 | Anhidrosis | 17.1% |
| 91 | Cholesteatoma | 17.1% |
| 92 | Pressure Ulcer | 17.1% |
| 93 | Folliculitis | 17.1% |
| 94 | Foot Dermatoses | 17.1% |
| 95 | Gynecomastia | 17.1% |
| 96 | Hypertrichosis | 17.1% |
| 97 | Hypohidrosis | 17.1% |
| 98 | Hypotrichosis | 17.1% |
| 99 | Leg Ulcer | 17.1% |
| 100 | Miliaria | 17.1% |
| 101 | Parakeratosis | 17.1% |
| 102 | Parapsoriasis | 17.1% |
| 103 | Pityriasis | 17.1% |
| 104 | Psoriasis | 17.1% |
| 105 | Sweet Syndrome | 17.1% |
| 106 | Hidradenitis | 17.1% |
| 107 | Onycholysis | 17.1% |
| 108 | Miliaria Rubra | 17.1% |
| 109 | Lichenoid Eruptions | 17.1% |
| 110 | Chloracne | 17.1% |
| 111 | Erythema Infectiosum | 17% |
| 112 | Exanthema Subitum | 16.9% |
| 113 | Dermatitis, Occupational | 16.8% |
| 114 | Breast Cyst | 16.7% |
| 115 | Actinic keratosis | 16.7% |
| 116 | Erythema Nodosum | 16.7% |
| 117 | Connective Tissue Diseases | 16.3% |
| 118 | Dermatitis, Allergic Contact | 16.2% |
| 119 | Toxic Epidermal Necrolysis | 16.2% |
| 120 | Stevens-Johnson Syndrome | 16.2% |
| 121 | Papillon-Lefevre Disease | 16.2% |
| 122 | Albinism | 15.8% |
| 123 | Diaper Rash | 15.4% |
| 124 | Tinea Capitis | 15.2% |
| 125 | Onychomycosis | 15.2% |
| 126 | Myxoma | 15.2% |
| 127 | Neoplasms, Bone Tissue | 15.2% |
| 128 | Neoplasms, Fibrous Tissue | 15.2% |
| 129 | Chondroma | 15.2% |
| 130 | Enchondroma | 15.2% |
| 131 | Mastocytosis, Systemic | 15% |
| 132 | Ecthyma | 14.6% |
| 133 | Giant Cell Tumor of Bone | 14.4% |
| 134 | Granuloma Annulare | 14.1% |
| 135 | Acantholysis | 13.9% |
| 136 | Pemphigoid, Benign Mucous Membrane | 13.9% |
| 137 | Pemphigus | 13.9% |
| 138 | Piedra | 13.9% |
| 139 | Sunburn | 13.9% |
| 140 | Hyperkeratosis, Epidermolytic | 13.9% |
| 141 | Ichthyosis, X-Linked | 13.9% |
| 142 | Sjogren-Larsson Syndrome | 13.8% |
| 143 | Hirsutism | 13.7% |
| 144 | Lactation Disorder | 13.7% |
| 145 | Mastitis | 13.7% |
| 146 | Urticaria | 13.7% |
| 147 | Adiposis Dolorosa | 13.7% |
| 148 | Pruritus Vulvae | 13.7% |
| 149 | Pruritus Ani | 13.6% |
| 150 | Behcet Syndrome | 13.2% |
| 151 | Fibrosarcoma | 12.9% |
| 152 | Osteosarcoma | 12.9% |
| 153 | Sarcoma | 12.8% |
| 154 | Hidradenitis Suppurativa | 12.2% |
| 155 | Lichen Planus | 12.1% |
| 156 | Pityriasis Rosea | 12.1% |
| 157 | Pityriasis Rubra Pilaris | 12.1% |
| 158 | Lichen Nitidus | 12.1% |
| 159 | Erythema Chronicum Migrans | 11.6% |
| 160 | Dermatomycoses | 11.6% |
| 161 | Mucocutaneous Lymph Node Syndrome | 11.6% |
| 162 | Skin Diseases, Bacterial | 11.6% |
| 163 | Drug Eruptions | 11.5% |
| 164 | Lipodystrophy | 11.5% |
| 165 | Livedo Reticularis | 11.5% |
| 166 | Malignant Atrophic Papulosis | 11.5% |
| 167 | Polyarteritis Nodosa | 11.4% |
| 168 | Takayasu Arteritis | 11.4% |
| 169 | leiomyosarcoma | 11.3% |
| 170 | liposarcoma | 11.3% |
| 171 | Angiomyolipoma | 11.3% |
| 172 | Alveolar Soft Part Sarcoma | 11.3% |
| 173 | Breast Neoplasms, Male | 11.2% |
| 174 | Triple Negative Breast Neoplasms | 11.2% |
| 175 | Peutz-Jeghers Syndrome | 11.1% |
| 176 | Tinea Pedis | 10.9% |
| 177 | Carcinoma, Lobular | 10.8% |
| 178 | leukemia | 10.6% |
| 179 | Neoplasms, Germ Cell and Embryonal | 10.6% |
| 180 | Neoplasms, Glandular and Epithelial | 10.6% |
| 181 | Germ Cell Cancer | 10.6% |
| 182 | Malignant Fibrous Histiocytoma | 10.5% |
| 183 | Gastrointestinal Stromal Tumors | 10.2% |
| 184 | Dupuytren Contracture | 10.1% |
| 185 | Pigmentation Disorders | 10.1% |
| 186 | Carcinosarcoma | 10.1% |
| 187 | Hemangiosarcoma | 10.1% |
| 188 | lymphangiosarcoma | 10.1% |
| 189 | Nail-Patella Syndrome | 10.1% |
| 190 | Porphyrias, Hepatic | 10% |
| 191 | Mastocytosis | 9.9% |
| 192 | Alopecia | 9.9% |
| 193 | Sweating, Gustatory | 9.9% |
| 194 | Androgenetic Alopecia | 9.9% |
| 195 | Auriculotemporal Syndrome | 9.9% |
| 196 | Lice Infestations | 9.8% |
| 197 | Varicose Ulcer | 9.8% |
| 198 | Mycetoma | 9.7% |
| 199 | Urticaria Pigmentosa | 9.7% |
| 200 | Galactorrhea | 9.7% |
| 201 | Alopecia Areata | 9.7% |
| 202 | Collagen Diseases | 9.1% |
| 203 | Mixed Connective Tissue Disease | 9.1% |
| 204 | Mucinoses | 9.1% |
| 205 | fibroma | 9.1% |
| 206 | Fibromatosis | 9.1% |
| 207 | Osteoblastoma | 9.1% |
| 208 | Osteoma | 9.1% |
| 209 | Chondromatosis | 9.1% |
| 210 | Neuroectodermal Tumors | 8.8% |
| 211 | Histiocytic Disorders, Malignant | 8.5% |
| 212 | Larva Migrans | 8.3% |
| 213 | Leishmaniasis | 8.3% |
| 214 | Molluscum Contagiosum | 8.3% |
| 215 | Angioedema | 8.2% |
| 216 | Onchocerciasis | 8.2% |
| 217 | Dermatofibrosarcoma | 8.2% |
| 218 | Dermatofibrosarcoma Protuberans | 8.2% |
| 219 | Chromoblastomycosis | 8.1% |
| 220 | Dermatophytosis | 8.1% |
| 221 | Sporotrichosis | 8.1% |
| 222 | Tinea | 8.1% |
| 223 | Tinea Versicolor | 8.1% |
| 224 | Trichophytosis | 8.1% |
| 225 | Hyalohyphomycosis | 8.1% |
| 226 | Sarcoma, Myeloid | 8.1% |
| 227 | Acute Generalized Exanthematous Pustulosis | 8.1% |
| 228 | Lichen Planus, Oral | 7.9% |
| 229 | Neoplasms, Neuroepithelial | 7.7% |
| 230 | Gliomatosis cerebri | 7.7% |
| 231 | Cartilage Diseases | 7.6% |
| 232 | Rheumatism | 7.6% |
| 233 | Chondromalacia | 7.6% |
| 234 | Myxoid cyst | 7.5% |
| 235 | Lupus Erythematosus, Systemic | 7.4% |
| 236 | Overlap syndrome | 7.4% |
| 237 | Adenofibroma | 7.2% |
| 238 | Fibroadenoma | 7.2% |
| 239 | Carcinoma 256, Walker | 7.2% |
| 240 | CREST Syndrome | 7.2% |
| 241 | Warts | 7.2% |
| 242 | Sarcoma, Experimental | 7.1% |
| 243 | Phyllodes Tumor | 7.1% |
| 244 | Lipoma | 7.1% |
| 245 | Myoma | 7.1% |
| 246 | Angiolipoma | 7.1% |
| 247 | Myelolipoma | 7.1% |
| 248 | Smooth Muscle Tumor | 7.1% |
| 249 | Desmoplastic Small Round Cell Tumor | 7.1% |
| 250 | Hamartoma | 7.1% |
| 251 | Neoplasms, Hormone-Dependent | 7.1% |
| 252 | Neoplasms, Multiple Primary | 7.1% |
| 253 | Paraneoplastic Syndromes | 7.1% |
| 254 | Precancerous Conditions | 7.1% |
| 255 | Neoplasms, Second Primary | 7.1% |
| 256 | Lymphoma | 7.1% |
| 257 | Candidiasis, Chronic Mucocutaneous | 7% |
| 258 | Cutaneous Candidiasis | 7% |
| 259 | Erysipelas | 7% |
| 260 | Serum Sickness | 7% |
| 261 | Staphylococcal Skin Infections | 7% |
| 262 | Variegate Porphyria | 7% |
| 263 | Acute intermittent porphyria | 7% |
| 264 | Porphyria Cutanea Tarda | 7% |
| 265 | Erythrasma | 6.9% |
| 266 | Arthritis, Psoriatic | 6.9% |
| 267 | Giant Cell Arteritis | 6.8% |
| 268 | Temporal Arteritis | 6.8% |
| 269 | Rhabdomyosarcoma | 6.7% |
| 270 | Meningioma | 6.6% |
| 271 | Leishmaniasis, Cutaneous | 6.5% |
| 272 | Eczema Herpeticum | 6.5% |
| 273 | Fusariosis | 6.4% |
| 274 | Composite Lymphoma | 6.3% |
| 275 | Trophoblastic Neoplasms | 6.1% |
| 276 | melanoma | 6.1% |
| 277 | Leukemia, Experimental | 6.1% |
| 278 | Fibromatosis, Aggressive | 6% |
| 279 | Fibromatosis, Abdominal | 6% |
| 280 | Neurofibrosarcoma | 6% |
| 281 | Lymphangioleiomyomatosis | 5.8% |
| 282 | Scleromyxedema | 5.7% |
| 283 | Cyst | 5.7% |
| 284 | Neoplastic Processes | 5.7% |
| 285 | Neoplastic Syndromes, Hereditary | 5.7% |
| 286 | Pregnancy Complications, Neoplastic | 5.7% |
| 287 | Leukemia, Plasma Cell | 5.7% |
| 288 | Neoplasms, Experimental | 5.6% |
| 289 | Angioedemas, Hereditary | 5.6% |
| 290 | Hereditary Angioedema Type III | 5.6% |
| 291 | Hereditary Angioedema Types I and II | 5.6% |
| 292 | Epidermodysplasia Verruciformis | 5.6% |
| 293 | Herpes Labialis | 5.6% |
| 294 | Diabetic Foot | 5.5% |
| 295 | Endometrial Stromal Sarcoma | 5.5% |
| 296 | Adenoma | 5.5% |
| 297 | Ameloblastoma | 5.5% |
| 298 | Angiokeratoma | 5.5% |
| 299 | Carcinoma | 5.5% |
| 300 | Chordoma | 5.5% |
| 301 | Hemangioma | 5.5% |
| 302 | hemangiopericytoma | 5.5% |
| 303 | Lymphangioma | 5.5% |
| 304 | Mesenchymoma | 5.5% |
| 305 | Nevus | 5.5% |
| 306 | Teratoma | 5.5% |
| 307 | Hepatoblastoma | 5.5% |
| 308 | Mixed Tumor, Mullerian | 5.5% |
| 309 | Germinoma | 5.5% |
| 310 | Teratocarcinoma | 5.5% |
| 311 | Angiofibroma | 5.5% |
| 312 | Epithelioma | 5.5% |
| 313 | Staphylococcal Scalded Skin Syndrome | 5.5% |
| 314 | Blastomycosis | 5.5% |
| 315 | HIV-Associated Lipodystrophy Syndrome | 5.4% |
| 316 | Carcinoma, Ehrlich Tumor | 5.3% |
| 317 | Dermoid Cyst | 5.3% |
| 318 | Carcinoma, Lewis Lung | 5.3% |
| 319 | Leukemia, Radiation-Induced | 5.2% |
| 320 | Menkes Kinky Hair Syndrome | 5.2% |
| 321 | Cellulitis | 5.2% |
| 322 | Rhinoscleroma | 5% |
| 323 | Condylomata Acuminata | 4.9% |
| 324 | Furunculosis | 4.9% |
| 325 | furuncle | 4.9% |
| 326 | Sarcoma 180 | 4.9% |
| 327 | Basal cell carcinoma | 4.8% |
| 328 | Carcinoma, Papillary | 4.8% |
| 329 | Squamous cell carcinoma | 4.8% |
| 330 | Craniopharyngioma | 4.8% |
| 331 | Cystadenoma | 4.8% |
| 332 | Mesothelioma | 4.8% |
| 333 | Neuroectodermal Tumor, Melanotic | 4.8% |
| 334 | Neuroendocrine Tumors | 4.8% |
| 335 | Carcinoma, Basal Cell | 4.8% |
| 336 | Impetigo | 4.8% |
| 337 | carbuncle | 4.8% |
| 338 | Neoplasms, Radiation-Induced | 4.7% |
| 339 | Mesenteric Panniculitis | 4.6% |
| 340 | Panniculitis, Peritoneal | 4.6% |
| 341 | Tietze's Syndrome | 4.6% |
| 342 | Orbital Cellulitis | 4.6% |
| 343 | Myxedema | 4.6% |
| 344 | Multiple Endocrine Neoplasia | 4.5% |
| 345 | Alveolar rhabdomyosarcoma | 4.5% |
| 346 | Melanoma, Experimental | 4.5% |
| 347 | Plasmacytoma | 4.4% |
| 348 | Adenoma, Acidophil | 4.4% |
| 349 | Ganglioneuroma | 4.4% |
| 350 | Glioma | 4.4% |
| 351 | Malignant Glioma | 4.4% |
| 352 | Malignant histiocytosis | 4.4% |
| 353 | Histiocytic sarcoma | 4.4% |
| 354 | Thymoma | 4.4% |
| 355 | Rhabdomyoma | 4.2% |
| 356 | Noonan Syndrome | 4% |
| 357 | Osteochondritis | 3.9% |
| 358 | Polymyalgia Rheumatica | 3.9% |
| 359 | Leukemia L1210 | 3.9% |
| 360 | Leukemia P388 | 3.9% |
| 361 | Acanthoma | 3.9% |
| 362 | Cystadenocarcinoma | 3.9% |
| 363 | Mucoepidermoid Carcinoma | 3.9% |
| 364 | Osteogenesis Imperfecta | 3.9% |
| 365 | Choriocarcinoma | 3.8% |
| 366 | Keloid | 3.8% |
| 367 | Medulloblastoma | 3.7% |
| 368 | Marfan Syndrome | 3.7% |
| 369 | Hodgkin Disease | 3.7% |
| 370 | Lymphoma, Non-Hodgkin | 3.7% |
| 371 | Paraneoplastic Encephalomyelitis | 3.6% |
| 372 | Carcinoid Tumor | 3.6% |
| 373 | Neurilemmoma | 3.6% |
| 374 | Hutchinson's Melanotic Freckle | 3.6% |
| 375 | Melanoma, Amelanotic | 3.6% |
| 376 | Mammary Neoplasms, Experimental | 3.6% |
| 377 | Tuberous Sclerosis | 3.6% |
| 378 | Homocystinuria | 3.6% |
| 379 | Abdominal Neoplasms | 3.5% |
| 380 | Erythroplasia | 3.5% |
| 381 | Follicular cyst | 3.5% |
| 382 | Head and Neck Neoplasms | 3.5% |
| 383 | Mucocele | 3.5% |
| 384 | Pilonidal Cyst | 3.5% |
| 385 | Soft Tissue Neoplasms | 3.5% |
| 386 | Thoracic Neoplasms | 3.5% |
| 387 | Thyroglossal Cyst | 3.5% |
| 388 | Synovial Cyst | 3.5% |
| 389 | Aberrant Crypt Foci | 3.5% |
| 390 | Nephroblastoma | 3.5% |
| 391 | Rheumatoid Arthritis | 3.4% |
| 392 | Juvenile arthritis | 3.4% |
| 393 | Lupus Nephritis | 3.2% |
| 394 | Primary amyloidosis | 3.2% |
| 395 | Retinoblastoma | 3.1% |
| 396 | Adenocarcinoma | 3% |
| 397 | Carcinoma in Situ | 3% |
| 398 | Carcinoma, Transitional Cell | 3% |
| 399 | Dysgerminoma | 3% |
| 400 | Hemangioendothelioma | 3% |
| 401 | Neuroma | 3% |
| 402 | Papilloma | 3% |
| 403 | Pseudomyxoma Peritonei | 3% |
| 404 | Seminoma | 3% |
| 405 | Papillomatosis | 3% |
| 406 | Adenomatosis, Pulmonary | 3% |
| 407 | Adenomatous Polyps | 3% |
| 408 | Carcinoma, Large Cell | 3% |
| 409 | Carcinoma, Small Cell | 3% |
| 410 | Lymphomatoid Granulomatosis | 3% |
| 411 | Laryngomalacia | 3% |
| 412 | Digestive System Neoplasms | 2.9% |
| 413 | Endocrine Gland Neoplasms | 2.9% |
| 414 | Eye Neoplasms | 2.9% |
| 415 | Nervous System Neoplasms | 2.9% |
| 416 | Pectus carinatum | 2.9% |
| 417 | Bowen's Disease | 2.9% |
| 418 | Paraganglioma | 2.9% |
| 419 | Bone neoplasms | 2.9% |
| 420 | Leukoplakia | 2.9% |
| 421 | Lymphocele | 2.9% |
| 422 | Pancreatic Cyst | 2.9% |
| 423 | Hematologic Neoplasms | 2.9% |
| 424 | Barrett Esophagus | 2.8% |
| 425 | Mediastinal Cyst | 2.8% |
| 426 | Neoplasm Invasiveness | 2.8% |
| 427 | Neoplasm Metastasis | 2.8% |
| 428 | Neoplasm Recurrence, Local | 2.8% |
| 429 | Parovarian Cyst | 2.8% |
| 430 | Pericardial Cyst | 2.8% |
| 431 | Splenic Neoplasms | 2.8% |
| 432 | Thymic Cyst | 2.8% |
| 433 | Carcinogenesis | 2.8% |
| 434 | Metastasis | 2.8% |
| 435 | Astrocytoma | 2.8% |
| 436 | Ependymoma | 2.8% |
| 437 | oligodendroglioma | 2.8% |
| 438 | Ganglioglioma | 2.8% |
| 439 | gliosarcoma | 2.8% |
| 440 | Anaplastic astrocytoma | 2.8% |
| 441 | Anaplastic Oligodendroglioma | 2.8% |
| 442 | Rheumatoid Nodule | 2.7% |
| 443 | Mesoblastic Nephroma | 2.7% |
| 444 | Basal Cell Nevus Syndrome | 2.6% |
| 445 | Waldenstrom Macroglobulinemia | 2.5% |
| 446 | Multiple Myeloma | 2.5% |
| 447 | Leukemia, Myelomonocytic, Chronic | 2.4% |
| 448 | Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative | 2.4% |
| 449 | Malignant Carcinoid Syndrome | 2.4% |
| 450 | Multiple Endocrine Neoplasia Type 1 | 2.3% |
| 451 | Corpus Luteum Cyst | 2.3% |
| 452 | Ovarian Cysts | 2.3% |
| 453 | Felty Syndrome | 2.3% |
| 454 | Hepatocellular Adenoma | 2.3% |
| 455 | Bronchomalacia | 2.3% |
| 456 | Tracheomalacia | 2.3% |
| 457 | Liver Neoplasms, Experimental | 2.3% |
| 458 | Parathyroid Neoplasms | 2.2% |
| 459 | Peritoneal Neoplasms | 2.2% |
| 460 | Thyroid Neoplasm | 2.2% |
| 461 | Thyroid carcinoma | 2.2% |
| 462 | Sturge-Weber Syndrome | 2.1% |
| 463 | Choledochal Cyst | 2% |
| 464 | Rheumatoid Vasculitis | 2% |
| 465 | Hemangioma, Cavernous | 2% |
| 466 | Carcinoma, Pancreatic Ductal | 2% |
| 467 | Prolactinoma | 2% |
| 468 | Growth Hormone-Secreting Pituitary Adenoma | 2% |
| 469 | Leukemia, T-Cell | 2% |
| 470 | Leukemia, B-Cell | 2% |
| 471 | neurofibroma | 2% |
| 472 | Lymphoma, Follicular | 2% |
| 473 | T-Cell Lymphoma | 2% |
| 474 | Mantle cell lymphoma | 2% |
| 475 | Mucopolysaccharidosis III | 2% |
| 476 | Glioblastoma | 2% |
| 477 | Neuroblastoma | 2% |
| 478 | Glioblastoma Multiforme | 2% |
| 479 | Pheochromocytoma | 1.9% |
| 480 | Pancreatic Neoplasm | 1.9% |
| 481 | Adenomatous Polyposis Coli | 1.9% |
| 482 | Hydatidiform Mole | 1.9% |
| 483 | Retroperitoneal Neoplasms | 1.8% |
| 484 | Sicca Syndrome | 1.8% |
| 485 | Sjogren's Syndrome | 1.8% |
| 486 | Adenoid Cystic Carcinoma | 1.8% |
| 487 | Adenocarcinoma, Clear Cell | 1.8% |
| 488 | Cholangiocarcinoma | 1.8% |
| 489 | Cervical Intraepithelial Neoplasia | 1.8% |
| 490 | Hemangioblastoma | 1.8% |
| 491 | Lymphoma, Extranodal NK-T-Cell | 1.8% |
| 492 | granulosa cell tumor | 1.8% |
| 493 | Carcinoma, Ovarian Epithelial | 1.8% |
| 494 | Acoustic Neuroma | 1.8% |
| 495 | Tracheal Neoplasms | 1.7% |
| 496 | Leukoplakia, Oral | 1.6% |
| 497 | Paraneoplastic Cerebellar Degeneration | 1.6% |
| 498 | Lupus Vasculitis, Central Nervous System | 1.6% |
| 499 | Optic Nerve Glioma | 1.6% |
| 500 | Ganglioneuroblastoma | 1.6% |
| 501 | Carcinoid Heart Disease | 1.6% |
| 502 | Mouth Neoplasms | 1.5% |
| 503 | Central Nervous System Neoplasms | 1.5% |
| 504 | Vascular Neoplasms | 1.5% |
| 505 | Thymus Neoplasms | 1.5% |
| 506 | Genital Neoplasms, Female | 1.5% |
| 507 | Pancreatic Pseudocyst | 1.5% |
| 508 | Lymphatic Metastasis | 1.5% |
| 509 | Neoplasms, Unknown Primary | 1.5% |
| 510 | Leukemic Infiltration | 1.5% |
| 511 | Neoplasm Micrometastasis | 1.5% |
| 512 | Mucopolysaccharidosis II | 1.5% |
| 513 | Leukemia, Myeloid, Chronic-Phase | 1.4% |
| 514 | Vipoma | 1.4% |
| 515 | Esophageal Neoplasms | 1.4% |
| 516 | Limbic Encephalitis | 1.4% |
| 517 | Denys-Drash Syndrome | 1.4% |
| 518 | Nasopharyngeal carcinoma | 1.4% |
| 519 | insulinoma | 1.3% |
| 520 | Lambert-Eaton Myasthenic Syndrome | 1.3% |
| 521 | Testicular Neoplasms | 1.3% |
| 522 | Adrenal Gland Neoplasms | 1.3% |
| 523 | Gastrointestinal Neoplasms | 1.3% |
| 524 | Genital Neoplasms, Male | 1.3% |
| 525 | Liver neoplasms | 1.3% |
| 526 | Uveal Neoplasms | 1.3% |
| 527 | Urologic Neoplasms | 1.2% |
| 528 | Spinal Neoplasms | 1.2% |
| 529 | Bone Marrow Neoplasms | 1.2% |
| 530 | Polycystic Ovary Syndrome | 1.2% |
| 531 | Adrenocortical carcinoma | 1.2% |
| 532 | Klatskin Tumor | 1.2% |
| 533 | Precursor B-Cell Lymphoblastic Leukemia-Lymphoma | 1.2% |
| 534 | Leukemia, Large Granular Lymphocytic | 1.2% |
| 535 | Precursor T-Cell Lymphoblastic Leukemia-Lymphoma | 1.2% |
| 536 | Lymphoma, T-Cell, Cutaneous | 1.2% |
| 537 | Lymphoma, AIDS-Related | 1.2% |
| 538 | Enteropathy-Associated T-Cell Lymphoma | 1.2% |
| 539 | Primary Effusion Lymphoma | 1.2% |
| 540 | Thyroid Nodule | 1.2% |
| 541 | Opsoclonus-Myoclonus Syndrome | 1.2% |
| 542 | Leydig Cell Tumor | 1.1% |
| 543 | Gastrinoma | 1.1% |
| 544 | Glucagonoma | 1.1% |
| 545 | Renal Cell Carcinoma | 1.1% |
| 546 | Papillary Renal Cell Carcinoma | 1.1% |
| 547 | Myelitis, Transverse | 1% |
| 548 | Carcinoma, Endometrioid | 1% |
| 549 | ovarian neoplasm | 0.9% |
| 550 | Burkitt Lymphoma | 0.9% |
| 551 | Nose Neoplasms | 0.8% |
| 552 | Meningeal Neoplasms | 0.8% |
| 553 | Mycosis Fungoides | 0.8% |
| 554 | Lymphomatoid Papulosis | 0.8% |
| 555 | Plasmablastic lymphoma | 0.8% |
| 556 | Pituitary Adenoma | 0.8% |
| 557 | Pituitary Neoplasms | 0.8% |
| 558 | Zollinger-Ellison syndrome | 0.7% |
| 559 | Palatal Neoplasms | 0.7% |
| 560 | Ear Neoplasms | 0.7% |
| 561 | Eyelid Neoplasms | 0.7% |
| 562 | Lung Neoplasms | 0.7% |
| 563 | Pleural Neoplasms | 0.7% |
| 564 | Cell Transformation, Viral | 0.7% |
| 565 | Brain Neoplasms | 0.7% |
| 566 | Salivary Gland Neoplasms | 0.7% |
| 567 | Spinal Cord Neoplasms | 0.7% |
| 568 | Tongue Neoplasms | 0.7% |
| 569 | Uterine Neoplasms | 0.7% |
| 570 | Vaginal Neoplasms | 0.7% |
| 571 | Vulvar Neoplasms | 0.7% |
| 572 | Uterine Cancer | 0.7% |
| 573 | Fallopian Tube Neoplasms | 0.7% |
| 574 | Sezary Syndrome | 0.6% |
| 575 | Pharyngeal Neoplasms | 0.6% |
| 576 | Central Nervous System Cysts | 0.6% |
| 577 | Bile Duct Neoplasms | 0.6% |
| 578 | gallbladder neoplasm | 0.6% |
| 579 | Intestinal Neoplasms | 0.6% |
| 580 | Penile Neoplasms | 0.6% |
| 581 | Prostatic Neoplasms | 0.6% |
| 582 | Stomach Neoplasms | 0.6% |
| 583 | Polycythemia Vera | 0.6% |
| 584 | Laryngeal neoplasm | 0.5% |
| 585 | Bladder Neoplasm | 0.5% |
| 586 | Kidney Neoplasm | 0.5% |
| 587 | Ureteral Neoplasms | 0.5% |
| 588 | Urethral Neoplasms | 0.5% |
| 589 | Meningeal Carcinomatosis | 0.5% |
| 590 | Bronchial Neoplasms | 0.4% |
| 591 | Multiple Pulmonary Nodules | 0.4% |
| 592 | Supratentorial Neoplasms | 0.4% |
| 593 | Endometrial Neoplasms | 0.4% |
| 594 | Hypopharyngeal Neoplasms | 0.4% |
| 595 | Pleural Effusion, Malignant | 0.4% |
| 596 | Hypopharyngeal Cancer | 0.4% |
| 597 | Parotid Neoplasms | 0.3% |
| 598 | Prostatic Neoplasms, Castration-Resistant | 0.3% |
| 599 | Nelson Syndrome | 0.3% |
| 600 | Cecal Neoplasms | 0.3% |
| 601 | Duodenal Neoplasms | 0.3% |
| 602 | Nasopharyngeal Neoplasms | 0.3% |
| 603 | Colorectal Neoplasms | 0.3% |
| 604 | Brain Stem Neoplasms | 0.3% |
| 605 | Paranasal Sinus Neoplasms | 0.2% |
| 606 | Tonsillar Neoplasms | 0.2% |
| 607 | Cerebellar Neoplasms | 0.2% |
| 608 | Radicular Cyst | 0.2% |
| 609 | Appendiceal Neoplasms | 0.2% |
| 610 | Colonic Neoplasms | 0.2% |
| 611 | Rectal Neoplasms | 0.2% |
| 612 | Choroid Plexus Papilloma | 0.2% |
| 613 | Maxillary Sinus Neoplasms | 0.2% |
| 614 | Anus Neoplasms | 0.1% |
| 615 | Sigmoid Neoplasms | 0.1% |